Teva Pharmaceutical Industries (TEVA)
Add to Watchlists Create an AlertTeva Pharmaceutical Industries Liabilities:
25.36B for March 31, 2013Teva Pharmaceutical Industries Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 25.36B |
| Dec. 31, 2012 | 27.84B |
| Sept. 30, 2012 | 26.65B |
| June 30, 2012 | 26.13B |
| March 31, 2012 | 27.42B |
| Dec. 31, 2011 | 27.95B |
| Sept. 30, 2011 | 18.42B |
| June 30, 2011 | 16.47B |
| March 31, 2011 | 16.18B |
| Dec. 31, 2010 | 16.20B |
| Sept. 30, 2010 | 17.37B |
| June 30, 2010 | 15.86B |
| March 31, 2010 | 14.40B |
| Dec. 31, 2009 | 13.99B |
| Sept. 30, 2009 | 14.03B |
| June 30, 2009 | 14.44B |
| March 31, 2009 | 16.11B |
| Dec. 31, 2008 | 16.60B |
| Sept. 30, 2008 | 10.12B |
| June 30, 2008 | 9.945B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
TEVA Liabilities Benchmarks
| Companies | |
|---|---|
| Pfizer | 105.15B |
| Mylan | 9.014B |
| Alexza Pharmaceuticals | 46.53M |
TEVA Liabilities Rankings
| Overall |
35th percentile 5185 of 8011 |
| Sector |
10th percentile 613 of 687 in Healthcare |
| Industry |
10th percentile 62 of 69 in Drug Manufacturers - Specialty & Generic |
TEVA Liabilities Range, Past 5 Years
| Minimum | 9.945B | Jun 2008 |
| Maximum | 27.95B | Dec 2011 |
| Average | 18.57B |
